AU2003254902A1 - Myocardial cell protecting agents - Google Patents

Myocardial cell protecting agents

Info

Publication number: AU2003254902A1
Authority: AU; Australia
Prior art keywords: myocardial cell; protecting agents; cell protecting; agents; myocardial
Prior art date: 2002-08-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003254902A

Inventor

Masahiro Amakawa

Reiko Ikegami

Takahiko Murata

Tadashi Ohyama

Haruyoshi Ueo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kaken Pharmaceutical Co Ltd

Original Assignee

Kaken Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-09

Filing date

2003-08-08

Publication date

2004-02-25

2003-08-08 Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd

2004-02-25 Publication of AU2003254902A1 publication Critical patent/AU2003254902A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU2003254902A 2002-08-09 2003-08-08 Myocardial cell protecting agents Abandoned AU2003254902A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002234029		2002-08-09
JP2002-234029		2002-08-09
PCT/JP2003/010158 WO2004014412A1 (en)	2002-08-09	2003-08-08	Myocardial cell protecting agents

Publications (1)

Publication Number	Publication Date
AU2003254902A1 true AU2003254902A1 (en)	2004-02-25

Family

ID=31711884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003254902A Abandoned AU2003254902A1 (en)	2002-08-09	2003-08-08	Myocardial cell protecting agents

Country Status (3)

Country	Link
JP (1)	JPWO2004014412A1 (en)
AU (1)	AU2003254902A1 (en)
WO (1)	WO2004014412A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2005039625A1 (en) *	2003-10-28	2005-05-06	Rheoscience A/S	Growth hormone secretagogue receptor agonists
WO2007088681A1 (en)	2006-01-31	2007-08-09	National University Corporation Hokkaido University	Ghrelin production promoter
CN101657436A (en)	2007-02-09	2010-02-24	特兰齐姆制药公司	Macrocyclic ghrelin receptor modulators and using method thereof
AU2009242219B2 (en)	2008-04-28	2013-03-21	Janssen Pharmaceutica Nv	Benzocycloheptane and benzoxepine derivatives
EP2524697B1 (en) *	2010-01-15	2016-09-21	University of Miyazaki	Ghrelin for promoting recovery of animal under medical treatment
JP7430442B2 (en) *	2019-12-27	2024-02-13	クラシエ株式会社	Ghrelin receptor activator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2092718C (en) *	1990-10-25	2007-08-07	Grace H. W. Wong	Use of protective agents against reactive oxygen species
SE9703929D0 (en) *	1996-11-22	1997-10-28	Pharmacia & Upjohn Ab	Therapeutic use and method
ZA987383B (en) *	1997-08-19	2000-02-17	Lilly Co Eli	Treatment of congestive heart failure with growth hormone secretagogues.
DE60022683D1 (en) *	1999-12-28	2005-10-20	Kaken Pharma Co Ltd	NERVOUS PROTECTION PRODUCTS
AU2001274601A1 (en) *	2000-06-23	2002-01-02	Kaken Pharmaceutical Co., Ltd.	Preventives or remedies for heart failure

2003
- 2003-08-08 WO PCT/JP2003/010158 patent/WO2004014412A1/en active Application Filing
- 2003-08-08 JP JP2004527381A patent/JPWO2004014412A1/en active Pending
- 2003-08-08 AU AU2003254902A patent/AU2003254902A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004014412A1 (en)	2004-02-19
JPWO2004014412A1 (en)	2005-12-02

Publication	Publication Date	Title
AU2003206028A1 (en)	2003-09-09	Antidiabetic agents
AU2003265826A1 (en)	2004-03-29	Electrolyte
AU2003288586A1 (en)	2004-07-22	Electrode arrangement
AU2003279056A1 (en)	2004-04-23	Improved hydrogen storage materials
AUPS088702A0 (en)	2002-03-28	Electrolyte purgative
AU2003213065A1 (en)	2003-09-04	Novel insect cell line
AU2003242125A1 (en)	2003-12-12	Stereo-light double-junction photovolatic cell
AU2003270297A1 (en)	2004-03-29	Toolholder
AU2003268304A1 (en)	2004-03-29	Toolholder
AU2003294726A1 (en)	2004-06-18	Window-winding arrangement
AU2003242258A1 (en)	2003-12-31	Battery
AU2003292408A1 (en)	2004-07-14	Deployable structure
GB0206357D0 (en)	2002-05-01	Cells
AU2003263502A1 (en)	2004-05-04	Storage
AU2003254902A1 (en)	2004-02-25	Myocardial cell protecting agents
AU2003235122A1 (en)	2003-11-10	Cell death inhibitor
AU2002354472A1 (en)	2004-03-29	Combine
AU2003290818A1 (en)	2004-06-03	Topoisomerase-targeting agents
AU2002329533A1 (en)	2004-03-19	Battery holder
AU2003244148A1 (en)	2004-01-19	Antifungal agents for external use
AU2003269185A1 (en)	2004-04-08	Software protection
AU2002355026A1 (en)	2004-04-30	Combine
AU2003215804A1 (en)	2003-10-20	Antidiabetic agents
AU2003261666A1 (en)	2004-02-25	Pack assembly
AU2003207181A1 (en)	2003-09-02	Microorganism-trapping agent

Legal Events

Date	Code	Title	Description
2005-05-05	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase